Generic placeholder image

Current Medicinal Chemistry


ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Anti-Inflammatory Effect of 3,4-DHPEA-EDA [2-(3,4 -Hydroxyphenyl) ethyl (3S, 4E)- 4-Formyl-3-(2-Oxoethyl)Hex-4-Enoate] on Primary Human Vascular Endothelial Cells

Author(s): G. Sindona, A. Caruso, A. Cozza, S. Fiorentini, B. Lorusso, E. Marini, M. Nardi, A. Procopio and S. Zicari

Volume 19 , Issue 23 , 2012

Page: [4006 - 4013] Pages: 8

DOI: 10.2174/092986712802002536

Price: $65


Diets in which fat is significantly provided by olive oil and are relatively rich in vegetables, have been associated with a low incidence of cardiovascular diseases, mostly due to the presence of several phenolic compounds which have anti-oxidant and antiinflammatory properties. [1]. In this work, we describe the anti-inflammatory effect of 3,4-DHPEA-EDA in a cell model that we developed to mimic inflammatory injury of endothelium. This was based on the production of the proinflammatory chemokine CCL2, following in vitro stimulation of primary human endothelial cells. Pre-treatment of cells with 3,4-DHPEA-EDA resulted in a dosedependent inhibition of CCL2 secretion. The effect of 3,4-DHPEA-EDA on CCL2 expression was observed at the transcriptional level. Functional data have shown that 3,4-DHPEA-EDA diminished monocyte adhesion to HUVECs. These results point on the use of 3,4- DHPEA-EDA as a novel drug aimed to prevent or reduce inflammation of endothelium.

Keywords: Atherosclerosis, CCL2, 3, 4-DHPEA-EDA, endothelial cells, E-selectin, ICAM, inflammation, LPS, poliphenols, TNF-α, VCAM

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy